capecitabine

‘Patients taking long-term capecitabine may have problems with regards to fingerprint identification when they enter U.S. ports or other countries that require fingerprint identification and should be warned about this,’ he said.

Common Cancer Drug Destroys Patients Fingerprints | Impact Lab 2009

"The NCCTG is seeking to determine if the anticancer activity of the combination with lapatinib and capecitabine, which is an approved treatment for women with HER2-expressing breast cancer that is no longer responsive to trastuzumab, can be improved by the addition of IMC-A12."

Health News from Medical News Today 2008

5-Fluorouracil (5-FU) and oral analogues, such as capecitabine, remain one of the most useful agents for the treatment of colorectal adenocarcinoma.

BioMed Central - Latest articles 2009

Clinical data submitted by Roche to the watchdog shows it can typically offer patients an extra six weeks of life when added to the chemotherapy drugs capecitabine and oxaliplatin.

Avastin prolongs life but drug is too expensive for NHS patients, says Nice 2010

The second person in the room with Jeremiah Webber on the night that he died was thus shown to be a male on chemotherapy, which led to a possible resolution of the fingerprint issue: certain drugs used in the treatment of cancer, among them capecitabine, caused inflammation of the palms of the hands and the soles of the feet, leading to peeling and blistering of the skin and, over time, the loss of fingerprints.

The Whisperers John Connolly 2010

The second person in the room with Jeremiah Webber on the night that he died was thus shown to be a male on chemotherapy, which led to a possible resolution of the fingerprint issue: certain drugs used in the treatment of cancer, among them capecitabine, caused inflammation of the palms of the hands and the soles of the feet, leading to peeling and blistering of the skin and, over time, the loss of fingerprints.

The Whisperers John Connolly 2010

He was put on a low dose of capecitabine to prevent the disease returning.

Common Cancer Drug Destroys Patients Fingerprints | Impact Lab 2009

Now a senior doctor is telling patients taking the drug, capecitabine, to carry medical documents when they travel abroad.

Common Cancer Drug Destroys Patients Fingerprints | Impact Lab 2009

Separately, Pfizer said on Thursday that it would halt a breast-cancer study of its top-selling cancer drug Sutent, after patients showed no improvement in a clinical trial versus a chemotherapy drug called capecitabine.

Pfizer Touts Progress Amid Setbacks 2009

Martin Ledwick, of Cancer Research UK, said capecitabine was used to treat head and neck cancers, as well as breast, stomach and colon cancers.

Common Cancer Drug Destroys Patients Fingerprints | Impact Lab 2009